Clinical trials: Colitis, Microscopic
Chronic Diarrhea, Microscopic Colitis
Chronic Diarrhea Owing to Underlying Microscopic Colitis
The goal of this observational study is to search for accurate diagnoses for patients with chronic diarrhea and assess the prevalence of microscopic colitis.
- Trial name
- NCT06530836
- Where
- Egypt
- Volunteers
- 116 people
- Sponsor
- Zagazig University
Microscopic Colitis
Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis
The purpose of this research study is to compare how well two formulations of budesonide (budesonide MMX [Cortiment] and budesonide CR [Entocort]) work for treating patients with microscopic colitis.
- Trial name
- NCT05915104
- Testing
- Budesonide MMX®, Budesonide controlled ileal release (CR) capsules
- Where
- Canada
- Volunteers
- 80 people
- Sponsor
- University of Calgary
Lymphocytic Colitis
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of lymphocytic colitis.
- Trial name
- NCT01209208
- Testing
- Budesonide, Mesalamine
- Where
- Germany
- Volunteers
- 57 people
- Sponsor
- Dr. Falk Pharma GmbH
Colitis, Microscopic
Risk Factors for Microscopic Colitis
Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unknown.
- Trial name
- NCT02699333
- Where
- United States
- Volunteers
- 346 people
- Sponsor
- University of North Carolina, Chapel Hill
Collagenous Colitis
Rifaximin-treatment of Collagenous Colitis
The hypothesis of this study is that an altered gut microbiota is a contributory factor in initiating an inflammatory process in the colonic mucosa leading to collagenous colitis.
- Trial name
- XiCoCo (NCT03658993)
- Testing
- Rifaximin 550 MG
- Volunteers
- 50 people
- Sponsor
- Bonderup, Ole K., M.D.
Collagenous Colitis
Budesonide for Maintenance Treatment of Collagenous Colitis
The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.
- Trial name
- NCT00180076
- Testing
- Budesonide
- Where
- Germany
- Volunteers
- 75 people
- Sponsor
- Technische Universität Dresden
Induction and Maintaining Remission of Collagenous Colitis
SOIBD Collagenous Colitis Maintenance Study
This study aims to demonstrate the superiority of budesonide compared to placebo as maintenance therapy in keeping patients in remission over a one-year period
- Trial name
- SCCMS (NCT01278082)
- Testing
- Budesonide
- Where
- 2 sites in Germany, Sweden
- Volunteers
- 92 people
- Sponsor
- Dr. Falk Pharma GmbH
Collagenous Colitis
Long-Term Treatment of Collagenous Colitis With Budesonide
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued…
- Trial name
- NCT00139165
- Testing
- Budesonide, sigmoidoscopy
- Where
- 2 sites in Denmark
- Volunteers
- 36 people
- Sponsor
- Bonderup, Ole K., M.D.
Collagenous Colitis
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.
- Trial name
- NCT00450086
- Testing
- Budesonide, Mesalazine
- Where
- Germany
- Volunteers
- 92 people
- Sponsor
- Dr. Falk Pharma GmbH